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Abstract
Stauffer’s syndrome is a rare paraneoplastic manifestation of renal cell carcinoma which is characterized by
elevated alkaline phosphatase, erythrocyte sedimentation rate, -2-globulin, -glutamyl transferase, throm-
bocytosis, prolongation of prothrombin time and hepatosplenomegaly, in the absence of hepatic metastasis
and jaundice. In this case report, we report a patient who was admitted with fever, fatigue, abdominal pain,
weight loss and pruritus in whom renal cell carcinoma was incidentally found in the right kidney during an
initial workup.
© 2015 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. All rights reserved.
Introduction
Neoplasms can cause cholestasis and abnormal liver function tests
(LFTs) by liver metastases or occluding the common bile ducts
mechanically. Cholestasis with or without jaundice can be seen
in a variety paraneoplastic syndromes (PNS) related to malig-
nancies, especially in renal cell carcinoma (RCC) and malignant
lymphoproliferative disorders [1]. Stauffer, for the first time in
1961, described this PNS in a patient with renal adenocarcinoma
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and intrahepatic cholestasis without liver metastasis [2]. Stauf-
fer’s syndrome is a rare paraneoplastic manifestation of RCC that
is characterized by elevated alkaline phosphatase (ALP), erythro-
cyte sedimentation rate (ESR), -2-globulin, -glutamyl transferase
(GGT), thrombocytosis, prolongation of prothrombin time (PT), and
hepatosplenomegaly (HSM), in the absence of hepatic metastasis
and jaundice [2]. In this case report a Stauffer’s syndrome variant
associated with renal cell carcinoma and thrombocytopenia will be
discussed.
Case  report
A 48 year-old male patient who had fever, fatigue, abdominal pain,
weight loss and pruritus for a month was admitted to the internal
medicine clinic. His history revealed right flank pain, intermittent
fever, fatigue, and weight loss for the prior month. He did not
http://dx.doi.org/10.1016/j.afju.2015.05.005
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Table  1  Laboratory parameters before and after operation.
Variables Before the
operation
After the
operation
Alanine aminotransferase (IU/L) 100 51
Aspartate aminotransferase (IU/L) 127 48
Alkaline phosphatase (IU/L) 197 73
Gamma glutamyl transferase (IU/L) 143 63
Total bilirubin (mg/dL) 1.7 0.3
Total protein (mg/dL) 65 75
Albumin (mg/dL) 35 45
Prothrombin time (s) 17.3 14.1
ESR (mm) 67 28
White blood cell (×103 U/L) 5.17 5.40
Hemoglobin (g/dL) 11.9 13.1
Platelets (×103 U/L) 70 180
ESR: erythrocyte sedimentation rate.
have a history of chronic disease, smoking, alcohol or drug use.
His physical examination revealed a body temperature of 37.5 ◦C,
pulse of 105/min, arterial blood pressure of 100/60 mm Hg, and
respiratory rate of 18/min, examination of other systems was nor-
mal except hepatosplenomegaly. In laboratory work-up white blood
cell count was 5.17 ×  103/L, neutrophil count was 2.42 ×  103/L,
hemoglobin was 11.9 g/dL, platelet count was 70 ×  103/L, alanine
aminotransferase was 100 IU/L (10–50), aspartate aminotransferase
was 127 IU/L (10–50), ALP was 197 IU/L (40–130), GGT was
143 IU/L (10–71), total bilirubin was 1.7 mg/dL (<1.4), direct biliru-
bin was 0.73 mg/dL (<0.3), ESR was 67 mm (0–20), and PT was
17.3 s (11.5–14.5). In ultrasonography of upper abdomen, the size
of the right lobe of the liver was found increased and vertical
dimension was measured 18.5 cm, however border and eco-forming
mass lesion was not detected in the liver parenchyma. Gallblad-
der wall thickness was within normal limits, stone or mass within
the lumen was not observed. The common bile duct was in nor-
mal width and pathology was not detected within the lumen of
the common bile duct. Spleen size was increased (14.5 cm) and
borders were smooth. There was no ascites in the abdomen. To elu-
cidate the etiology of abnormal LFTs and the clinical situation, a
variety of tests were performed. Anti-mitochondrial antibody, anti-
nuclear antibody, anti-smooth muscle antibodies, anti-neutrophil
cytoplasmic antibody, TORCH, epstein barr virus, human immu-
nodeficiency virus, acute and chronic viral hepatitis markers were
negative for serological tests. In addition, iron, iron binding capacity,
ferritin, 24-h urine copper, ceruloplasmin, alpha-fetoprotein, alpha-
1 antitrypsin levels were within normal limits. In the peripheral
blood smear platelet counts were consistent with thrombocyto-
penia, anisopoikilocytosis was observed and there were no atypical
cells. Blood, urine, throat and sputum cultures were ordered for
the patient who had permament fever and cultures came out nega-
tive. According to the present findings, thorax, abdomen and pelvic
computed tomography (CT) scan was requested to screen malig-
nancy. In lower abdomen CT, a contrast holding mass lesion sized
25 ×  23 mm was detected in the lower pole of the right kidney, all
other structures were normal and no finding that suggests metastasis
was detected. According to these findings, patient was referred to
the urology clinic for right nephrectomy surgery. After two weeks,
partial nephrectomy was performed and pathology result was clear
cell type RCC. Three months after the operation, patient’s entire
laboratory parameters returned to normal (Table 1).
Discussion
Renal cell carsinoma may be seen with a lot of non-specific symp-
toms that are not kidney related. The classic triad is hematuria
in 50–60% of patients, palpable mass in 30–40% of patients and
abdominal pain in 40% of patients [3]. However the classic triad is
seen in only 9% of patients [4]. In our patient, only abdominal pain
was present. Most of the time RCC, as in our case, presents with
paraneoplastic and systemic symptoms. Stauffer’s syndrome which
is one of the PNS is characterized by elevated ALP, ESR, alpha-2
globulin, GGT levels, thrombocytosis, HSM, PT prolongation with-
out liver metastases and jaundice [5]. This PNS is characterized with
total improvement in laboratory tests after surgical removal of the
tumor [6]. Although the pathophysiology of this PNS is not fully
understood, overexpression of IL-6 by the primary tumor is con-
sidered to be involved [7]. Since 1961, many Stauffer syndrome
cases were presented in the literature. While the most cases were
characterized by classic Stauffer syndrome feature, jaundice was
only present in only a few cases [8]. In our case, abdominal pain,
weight loss, fever, rash, anemia, elevated ESR, impairment of LFTs,
PT prolongation, thrombocytopenia, HSM were present. All even-
tualities that may cause impairment of LFTs were excluded. The
malignancy scan revealed a mass in the right kidney. There was
no evidence of metastasis. The urology department operated the
patient and removed the mass. Three months after the surgery, all
laboratory parameters were improved. With these findings patient
was diagnosed with RCC related Stauffer’s syndrome related to
RCC. Although there was thrombocytosis in all the case reports in
the literature, in our case the patients’ preoperative platelet count
was 70 ×  103 U/L. In physical examination or laboratory tests, noth-
ing abnormal was found for the etiology of thrombocytopenia. The
patients’ platelet count one month after the surgery was increased to
180 ×  103 U/L. According to these clinical and laboratory findings,
we can say that RCC must be kept in mind in the etiology of patients
with systemic findings and abnormal LFTs. However, the fact that
thrombocytopenia may be seen in Stauffer syndrome must not be
forgotten.
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